60
Patient Safety Preanalytical Phase Vladimir Palicka Charles University Hradec Kralove, Czech Republic International Symposium “Patient Safety”, Prague, April 12

Patient Safety Preanalytical Phase

  • Upload
    lucius

  • View
    145

  • Download
    9

Embed Size (px)

DESCRIPTION

Patient Safety Preanalytical Phase. Vladimir Palicka Charles University Hradec Kralove, Czech Republic. International Symposium “ Patient Safety ” , Prague, April 12, 2013. Preanalytical Phase The Weakest Point in Quality Management. - PowerPoint PPT Presentation

Citation preview

Page 1: Patient Safety Preanalytical Phase

Patient SafetyPreanalytical Phase

Vladimir Palicka

Charles University

Hradec Kralove, Czech Republic

International Symposium “Patient Safety”, Prague, April 12, 2013

Page 2: Patient Safety Preanalytical Phase

Preanalytical PhaseThe Weakest Point in Quality

Management

International Symposium “Patient Safety”, Prague, April 12, 2013

Page 3: Patient Safety Preanalytical Phase

The value of laboratory testing for diagnostics and therapy

Quantitativeat minimum 80-90 % of all objective data

are results of laboratory or other complementary departments

Qualitativehigh quality information only are of value,

the others are dangerous

Page 4: Patient Safety Preanalytical Phase

To err is human:building a safer health system

Kohn LT, Corrigan JM, Donaldson MS

National Academy Press, Washington, DC, 2000

Page 5: Patient Safety Preanalytical Phase

Errors in medicine

10-20 % of errors negatively influence health care quality

> 3 % of errors are of direct influence on patient safety

„the more tests, the more errors“

Page 6: Patient Safety Preanalytical Phase

Laboratory error

A defect occurring at any part of the laboratory cycle, from ordering tests to

reporting results and appropriately interpreting and reacting to these

ISO/PDTS 22367

Page 7: Patient Safety Preanalytical Phase

negative/risky trends for quality

Consolidation pre-analytical phase

Decentralization (POCT) analytical quality

Outsourcing pre- and post-analytical

Downsizing, shortages total quality

Page 8: Patient Safety Preanalytical Phase

positive trends for quality

Integration of automatization and informatics

improved process control

Standard Operation Procedures

reduction of errors in all phases

Improved contact with clinicians

pre- and post-analytical phase

Page 9: Patient Safety Preanalytical Phase

Errors in laboratory medicine

analyticsapprox 15 % (7-13%)

preanalyticsapprox 62 % (46 – 68%)

postanalyticsapprox 23 % (18 – 45%)

Page 10: Patient Safety Preanalytical Phase

Total Testing Process Improvement

prevalence of errors was reduced by

automation

improved laboratory technology

assay standardization

informatics

but mostly in analytical part !

Page 11: Patient Safety Preanalytical Phase
Page 12: Patient Safety Preanalytical Phase

Most common reasons of pre-analytical errors

Haemolysis

Misidentification

Sampling error (wrong tube, inappropriate amount of the sample)

Clotting

Sample and/or request missing

Wrong patient preparation

Page 13: Patient Safety Preanalytical Phase

Preanalytical errors

Retrospective analysis

2001-2005

4.715.132 samples in 105 labs

The most common reason for sample rejection

Missing sample (37.5%)

Haemolysis (29.3%)

(serum 38.6%, plasma 68.4%)

Alsina J: CCLM 2008, 46: 849

Page 14: Patient Safety Preanalytical Phase

preanalytical errors

misidentification

wrong sampling

pumping with fist

wet skin

tourniquet time

sample mixing (inverting)

time for transport and centrifugation

Page 15: Patient Safety Preanalytical Phase

Detection of inappropriateness

Visual inspection of lipaemic, icteric and/or haemolysed samples is

highly unreliable

and should be replaced by automated systems (serum indices)

Page 16: Patient Safety Preanalytical Phase
Page 17: Patient Safety Preanalytical Phase

Haemolysis

upper „reference limit“ for free Hb

plasma 20 mg/l

serum 50 mg/l

Visible haemolysis after centrifugation

free Hb > 300 mg/l = 18.8 mmol/l

(approximately 0.5% of Ery are lysed)

Page 18: Patient Safety Preanalytical Phase

Haemolysis - reasons

in vivo – in vitroUp to 2% samples are haemolysedAt minimum 50 possible reasons

inherited-acquired haemolytic anaemiahaemoglobinopathias

HELLP syndromedrugs, infection

artificial heart valvestransfusion of incompatible blood

Page 19: Patient Safety Preanalytical Phase

Haemolysis – common reasons

in vivo – in vitro

Wet skin at sampling site

Thin needle (usually < 21 G)

Difficult venipucture

Fragile veins

Vacuum in tube is too high

Wrong amount of blood for the amount of additive (anticoagulant)

Page 20: Patient Safety Preanalytical Phase

Haemolysis - reasons

Inappropriate shaking the sampleTemperature discomfortHigh centrifugation force

Long centrifugationTo early centrifugation

Late serum/plasma separationWrong separation barrier

Re-centrifugation of gel-tubesPneumatic sample transporting

Page 21: Patient Safety Preanalytical Phase

Haemolysis

The most common reasons of the wrong samples

Frequency

40 – 70% of all rejected samples(5-times more than any other reason)

Page 22: Patient Safety Preanalytical Phase

Haemolysis according dept

Lippi G, CCLM 47: 616, 2009

Page 23: Patient Safety Preanalytical Phase

Haemolysis

increased concentration/activity:

AST, ALT, CK, LDH, lipase

creatinine, urea, Fe, Mg, P, K

decreased concentration/activity:

ALP, GGT

Alb, bilirubin, Cl, G, Na

Special care: newborn bilirubin !!

Page 24: Patient Safety Preanalytical Phase

Haemolysis

Immunoassay

False negative troponin T

False increase of troponin I

False increase of PSA

Negative bias: testosterone, cortisol, FPIA

Impossibility to measure:

insulin, glukagon, CT, PTH, ACTH, gastrin

Page 25: Patient Safety Preanalytical Phase

In the case of haemolysis

a) Correction of result(s)

b) Release of results with flags and comments

c) Information of ward and new-sample request

Page 26: Patient Safety Preanalytical Phase

In the case of haemolysis

a) Result correction

Methods with known interference (nm) rejected

Release „unaffected“ results, only

Potassium results corrected by recalculation

Page 27: Patient Safety Preanalytical Phase

Should we correct the results ?

Haemolysis: potassium

Linear correlation

Should we use the „index“ or measured concentration ?

different analyzers – different indexes

different calculation of corrected K =

K measured – (Hb mmol/l x 5.2)

K measured– (Hb mmol/l x 10)

Bland-Altman: uncertainty ± 0.4 mmol/l

Page 28: Patient Safety Preanalytical Phase

In the case of haemolysis

a) Result correction

Methods with known interference (nm) rejected

Release „unaffected“ results, only

Potassium results corrected by recalculation

incorrect, error is too big !

intravascular haemolysis ?

Page 29: Patient Safety Preanalytical Phase

In the case of haemolysis

b) Release of results with flags and comments

Many types of comments

Wrong decision is quite common

Credibility of lab decreases

Extreme situations?

Page 30: Patient Safety Preanalytical Phase

In the case of haemolysis

c) Information of ward and new-sample request

Nonconformity notification

Laboratory book and hospital rules

Quick reaction is necessary

New sample request

Page 31: Patient Safety Preanalytical Phase

In the case of haemolytic sample

Information to ward

Consultation

New sample request

Page 32: Patient Safety Preanalytical Phase

To err is humanbuilding a safer health system

Kohn LT, Corrigan JM, Donaldson MS

National Academy Press, Washington, DC, 2000

Page 33: Patient Safety Preanalytical Phase

To err is human

to delay is deadly

Consumer Reports – Health

Safe Patient Project.org

Page 34: Patient Safety Preanalytical Phase

Patient Identification Errors

Page 35: Patient Safety Preanalytical Phase

EQA - PAPA

Australia, New Zealand

12-year period

59 participating laboratories

3.9 million specimens

PAPA incident rate: 1.22 %

most significant incident

Patient or Sample Identification !

Page 36: Patient Safety Preanalytical Phase

Quality System Requirements

ISO 15189:2007

SOPs

JCI:

at least two patient identifiers

Bracelets

bar-codes

RFID (radiofrequency identifier devices)

automated systems

Page 37: Patient Safety Preanalytical Phase

The most common system

Patient – Wards

Wrist-bands, electronic order, bar-code sticks

Laboratory

Data terminal

Hand-held bare code scanner

Portable label printer

software

Page 38: Patient Safety Preanalytical Phase

systems for patient identification

barcodes

Page 39: Patient Safety Preanalytical Phase

Bar codes

History: local grocery, 1948

Patent was applied for 1949

Patent issued 1952

Today: more that 2 dozen different linear bar code symbologies

Most frequent used: Code 128, Code 39

Error rate expected 1:400.000 – 1.800.000

Page 40: Patient Safety Preanalytical Phase

Most common sources of errors

Printing defect in the barcode

Suboptimal barcode orientation

Lack of error detection

Scanner resolution

Sasavage N: Clin.Lab.News, 2011, Jan

Page 41: Patient Safety Preanalytical Phase

Errors in bar code technology

More often in POCT

More often on wristband than on paper

Take care about printer heads

Thick black line

Turn the label stock by 90o

Snyder ML, Clin.Chem. 2010, 56:1554

Page 42: Patient Safety Preanalytical Phase

Sasavage N: Clin.Lab.News, 2011, Jan

Page 43: Patient Safety Preanalytical Phase

Sasavage N: Clin.Lab.News, 2011, Jan

Page 44: Patient Safety Preanalytical Phase

Sasavage N: Clin.Lab.News, 2011, Jan

Page 45: Patient Safety Preanalytical Phase

Errors in bar code technology

More often in POCT

More often on wristband than on paper

Take care about printer heads

Thick black line

Turn the label stock by 90o

Quality program

Cleaning and bar code verifier use

Snyder ML, Clin.Chem. 2010, 56:1554

Page 46: Patient Safety Preanalytical Phase

systems for patient identification

barcodes

radio frequency identification (RFID)

biometrics

magnetic stripes

optical character recognition

„smart“ cards

voice recognition

Page 47: Patient Safety Preanalytical Phase

causes of patient misidentification

identical names

Page 48: Patient Safety Preanalytical Phase

China example

60 in-patient sampled

in 32 of them (53 percent)

common full name shared with

1 – 101 other patients

attending the same hospital (Hong Kong)

Lee AC: Int.J.Health Care Qual.Assur.Inc.Leadersh.Health Serv., 2005:18/1:15

Page 49: Patient Safety Preanalytical Phase

Astion M: Clin.Lab.News 20110,Jan

Page 50: Patient Safety Preanalytical Phase

causes of patient misidentification

identical names

wristband „problems“

CAP: 2.6 % errors

(missing wristband, ID, illegible, incorrect)

Page 51: Patient Safety Preanalytical Phase

wristband errors

Join Commission on Accreditation

CAP – Q-Probes

mean wristband error rates

5.4 – 8.4 %

after the introduction of QIM

< 1.0 %

Page 52: Patient Safety Preanalytical Phase

wristband errors

4-years study

464 bed public hospital

bar-coded wristbands

total wristband error rates 10.6-16.5%

training sessions

total wristband error rates 0.4-1.5%

Dhatt GS: CCLM 2001, 49/5: ??

Page 53: Patient Safety Preanalytical Phase

wristband errors

2 hospitals in Sweden (230+152 beds)

295 nurses/phlebotomists

questionnaire

undesirable practice

9.6% not asking name and ID

17% not checking identity

79% not checking wristband during ID

43% using health care card for ID

Wallin O: Scand.J.Caring Sci. 2010, 24/3: 581

Page 54: Patient Safety Preanalytical Phase

Patient Identification Errors

differences between type of labs

transfusion medicine 0.05 %

clinical chemistry up to 1 %

most common reasons

malpractice (low interest), low adherence to QSR

high workflow

wrong technique

Page 55: Patient Safety Preanalytical Phase

What about relabeling

Very strict policy

Blood and urine rarely will be candidates

Sometimes indicated for irreplaceable specimens

(cerebrospinal fluid, bone marrow, surgical)

The risk of recollection is greater than a risk for relabeling…

SOP

Astion M: Clin.Lab.News 20110,Jan

Page 56: Patient Safety Preanalytical Phase

home mesage

identification mistakes are not easily detectable

no immediate harm or signal

many steps – no personal responsibility

mostly not systematic

not considered as the big problem

fear of blame

human factor involved

Page 57: Patient Safety Preanalytical Phase

home mesage

patient identification is common duty of clinicians, phlebotomists and clinical chemists

technical equipment is necessary

(but must be under the control)

ISO, SOP, EQA are extremely important

education and enthusiasm of people is the corner stone

Page 58: Patient Safety Preanalytical Phase

home mesage

before any test we should be sure whom

are we testing !

Page 59: Patient Safety Preanalytical Phase

Patient safety

and proper care

is the target !

Page 60: Patient Safety Preanalytical Phase